| Novartis Pharma Schweiz AG - Tabrecta 150 mg, Filmtabletten | | 67648 | | 01 | | Tabrecta 150 mg | | Filmtabletten | | L01EX17 | | Capmatinib | | 26.04.2021 | | |
| | Composition | | capmatinibum 150 mg ut capmatinibi hydrochloridum monohydricum, cellulosum microcristallinum, mannitolum, crospovidonum, povidonum K 30, magnesii stearas, silica colloidalis anhydrica, natrii laurilsulfas corresp. natrium 0.12 mg, Überzug: hypromellosum, E 171, macrogolum 4000, talcum, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Capmatinibum | 150 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Capmatinibum | 150 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | (Rubrum) | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 4000 | | | Magnesii Stearas | | | | Mannitol | | | | Natrii Laurilsulfas | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 120 | 5503.34 | 5954.25 | A | LS | Oui |
|
|
